Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

BACKGROUND: Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet
Main Authors: Parker, Chris C, Clarke, Noel W, Cook, Adrian D, Kynaston, Howard, Catton, Charles N, Cross, William R, Petersen, Peter M, Persad, Rajendra A, Saad, Fred, Bower, Lorna C, Logue, John, Payne, Heather, Forcat, Silvia, Goldstein, Cindy, Murphy, Claire, Anderson, Juliette, Barkati, Maroie, Bottomley, David M, Branagan, Jennifer, Choudhury, Ananya, Chung, Peter W M, Cogley, Lyn, Goh, Chee L, Hoskin, Peter, Khoo, Vincent, Malone, Shawn C, Masters, Lindsey, Morris, Stephen L, Nabid, Abdenour, Ong, Aldrich D, Raman, Rakesh, Tarver, Kathryn L, Tree, Alison C, Worlding, Jane, Wylie, James P, Zarkar, Anjali M, Parulekar, Wendy R, Parmar, Mahesh K B, Sydes, Matthew R
Formato: Artigo
Idioma:Inglês
Publicado: 2024
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616360/
https://ncbi.nlm.nih.gov/pubmed/38763154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(24)00548-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares